Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  New England Journal of Medicine

• Publication date

  2007-03-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMOA067722PMID 17296822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspects of sleep disorders in children and adolescents

  2009cited by this paper
• Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.

  2008cited by this paper
• Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

  2007cited by this paper
• Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-Year Follow-Up of the e-Cypher Registry

  2006cited by this paper
• Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.

  2006cited by this paper
• Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

  2006cited by this paper
• Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.

  2006cited by this paper
• Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

  2006cited by this paper
• On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]).

  2006cited by this paper
• Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

  2006cited by this paper
• Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

  2006cited by this paper
• Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study.

  2005cited by this paper
• Peristent Remodeling and Neointimal Suppression 2 Years After Polymer-Based, Paclitaxel-Eluting Stent Implantation: Insights From Serial Intravascular Ultrasound Analysis in the TAXUS II Study

  2005cited by this paper
• What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.

  2005cited by this paper
• The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice.

  2005cited by this paper
• The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.

  2005cited by this paper
• Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

  2005cited by this paper
• A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.

  2004cited by this paper
• A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

  2004cited by this paper
• Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).

  2004cited by this paper
• Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?

  2004cited by this paper
• Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study

  2004cited by this paper
• Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

  2003cited by this paper
• Analysis of survival by tumor response.

  1983cited by this paper
• The central role of the propensity score in observational studies for causal effects

  1983cited by this paper

• Donor-Recipient Age Mismatch and Long-Term Graft Outcomes After Adolescent Liver Transplant

  2026cites this paper
• Safety and Efficacy of Different Stent Strategies in Percutaneous Coronary Intervention

  2025cites this paper
• A Review of Nanomaterials and Microwave Synthesized Metal Oxides Nanoparticles in Schistosomiasis Diagnosis

  2025influential citation
• Evolution of Coronary Stents: From Birth to Future Trends

  2025influential citation
• Finite element simulation and experimental verification of laser machining of nitinol tubes

  2025cites this paper
• Research progress of absorbable stents

  2024cites this paper
• Do responses to news matter? Evidence from interventional cardiology.

  2024cites this paper
• Optimising Percutaneous Coronary Interventions: The Impact of Stent Type and Diameter on Long-Term Clinical Outcomes in Large Coronary Arteries

  2024cites this paper
• Very short sleep duration reveals a proteomic fingerprint that is selectively associated with incident diabetes mellitus but not with incident coronary heart disease: a cohort study

  2024cites this paper
• The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population

  2024cites this paper
• Major Adverse Cardiovascular Events Following Coronary Artery Stenting by History of Hypertensive Disorder of Pregnancy

  2024cites this paper
• Advances in Technology and Technique in Percutaneous Coronary Intervention: A Clinical Review

  2024influential citation
• Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock After the SHOCK-II Trial.

  2023cites this paper
• An "Old" Problem in Need of New Solutions.

  2023cites this paper
• Evaluation of coronary stents: A review of types, materials, processing techniques, design, and problems

  2023cites this paper
• Toward Optimizing Antiplatelet Therapy for Patients at High Bleeding Risk.

  2023cites this paper
• A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease

  2022cites this paper
• Drug-Coated Balloons for Acute Myocardial Infarction: A Metaanalysis of Randomized Clinical Trials

  2022cites this paper
• Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends

  2022cites this paper
• Current status and future direction of metallic and polymeric materials for advanced vascular stents

  2022cites this paper
• Disparities in Drug-Eluting Stent Utilization in Patients With Acute ST-Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample

  2022cites this paper
• Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations

  2022cites this paper
• Recurrent simultaneous two-vessel very late stent thrombosis

  2022cites this paper
• Frequency, Risk Factors, and Outcome of Definite Stent Thrombosis: A Single-Center Experience

  2022cites this paper
• The factors influencing the efficiency of drug-coated balloons

  2022cites this paper
• Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

  2022cites this paper
• Do we need to reconsider how we design and conduct randomized controlled trials?

  2022cites this paper
• Impact of stent types on in-hospital outcomes of patients with cancer undergoing percutaneous coronary intervention: A nationwide analysis.

  2022cites this paper
• [Echocardiographic risk score after acute coronary syndrome].

  2021cites this paper
• Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years).

  2021cites this paper
• Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease

  2021cites this paper
• P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: Is It Safe to Abandon Aspirin?

  2021cites this paper
• Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction

  2021cites this paper
• 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• Multimodality Intravascular Imaging of High-Risk Coronary Plaque.

  2021cites this paper
• Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

  2021cites this paper
• Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.

  2021cites this paper
• 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• A Microneedles Balloon Catheter for Endovascular Drug Delivery

  2021cites this paper
• Effect of Age on Clinical Outcomes in Elderly Patients (>80 Years) Undergoing Percutaneous Coronary Intervention: Insights From a Multi-Centre Australian PCI Registry.

  2021cites this paper
• Impact of genetic risk score on the association between male childlessness and cardiovascular disease and mortality

  2021cites this paper
• A protocol for systematic review and meta-analysis

  2021cites this paper
• In vitro corrosion study of PLA/Mg composites for cardiovascular stent applications.

  2021cites this paper
• Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model

  2021cites this paper
• The Impact of Out-of-Hours Presentation on Clinical Outcomes in ST-Elevation Myocardial Infarction.

  2020cites this paper
• Using Heparin-Coated Nanoparticles in the Treatment of Neointimal Hyperplasia

  2020cites this paper
• Cardiología intervencionista

  2020cites this paper
• Ideal coronary stent: development, characteristics, and vessel size impact

  2020cites this paper
• Cardiovascular Medicine in Sweden: Improvement by Continuous Measuring.

  2020cites this paper
• Stent thrombosis.

  2020cites this paper
• Evaluation of soft-plaque stenoses in coronary artery stents using conventional and monoenergetic images: first in-vitro experience and comparison of two different dual-energy techniques.

  2020cites this paper
• Mineralized manganese dioxide channel as the stent coating for in situ precise tumor navigation

  2020cites this paper
• Clinical safety and efficacy of World's thinnest (50 μm), very long (>40 mm) Everolimus Eluting Stent (SES) among real world patients.

  2020cites this paper
• Altered Acylcarnitine Metabolism Is Associated With an Increased Risk of Atrial Fibrillation

  2020cites this paper
• Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

  2020cites this paper
• The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome

  2020cites this paper
• Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review

  2020cites this paper
• Drug eluting stents versus bare-metal stents in large coronary artery revascularization; systematic review and meta-analysis.

  2020cites this paper
• The role of intracoronary imaging in translational research.

  2020cites this paper
• Reply: Swedish Coronary Angiography and Angioplasty Registry Scare on Drug-Coated Balloons: Is It Really Scary?

  2020cites this paper
• Engineering Nano-to-Micron-Patterned Polymer Coatings on Bioresorbable Magnesium for Controlling Human Endothelial Cell Adhesion and Morphology.

  2020cites this paper
• Optimizing Monotherapy Selection, Aspirin Versus P2Y12 Inhibitors, Following Percutaneous Coronary Intervention.

  2020cites this paper
• Temporal trends in patient risk profile and clinical outcomes following percutaneous coronary intervention.

  2020cites this paper
• Clinical outcomes following ST‐elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention

  2020cites this paper
• Improving outcomes of percutaneous coronary interventions in patients with stable ischemic heart disease

  2020cites this paper
• Results of PCI with Drug-Eluting Stents in an All-Comer Population Depending on Vessel Diameter

  2020cites this paper
• Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes

  2020cites this paper
• Biodegradable Stent/Tube for Pancreatic and Biliary Disease

  2020cites this paper
• Outcomes of cardiogenic shock complicating acute coronary syndromes

  2020cites this paper
• Reply

  2020cites this paper
• Intelligent H2S release coating for regulating vascular remodeling

  2020cites this paper
• The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention.

  2020cites this paper
• Wirelessly Powered Resonant-Heating Stent System: Design, Prototyping, and Optimization

  2020cites this paper
• Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study

  2020cites this paper
• Short- and Long-term Outcomes of Out-Of-Hospital Cardiac Arrest Following ST-elevation Myocardial Infarction Managed with Percutaneous Coronary Intervention.

  2020cites this paper
• Dual Antiplatelet Therapy: Is It Time to Cut the Cord With Aspirin?

  2019cites this paper
• Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Elevation Myocardial Infarction.

  2019cites this paper
• 21 Re-Stenosed Stents in the Presence of Adequate P2Y12 Inhibition: A Case Report

  2019influential citation
• Sildenafil Reduces Neointimal Hyperplasia after Angioplasty and Inhibits Platelet Aggregation via Activation of cGMP-dependent Protein Kinase

  2019cites this paper
• Drug-eluting versus bare-metal stents in primary PCI. Analysis of an 8-year registry

  2019cites this paper
• Stents farmacoactivos frente a met�licos en pacientes tratados con angioplastia primaria. An�lisis de un registro de 8 a�os

  2019cites this paper
• Experimental analysis on wireless heating of resonant stent for hyperthermia treatment of in-stent restenosis

  2019cites this paper
• Trends and predictors of recurrent acute coronary syndrome hospitalizations and unplanned revascularization after index acute myocardial infarction treated with percutaneous coronary intervention.

  2019cites this paper
• Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial

  2019cites this paper
• Three-year outcome of everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stents: a comprehensive updated meta-analysis of randomized controlled trials

  2019cites this paper
• Acute Myocardial Infarction

  2019cites this paper
• Abbreviated Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 12 Months’ Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2019cites this paper
• The effect of coronary stent type on the long-term results of coronary artery bypass surgery after stenting clinically related artery in acute coronary syndrome in patients with multivessel coronary artery disease

  2019cites this paper
• Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care

  2019cites this paper
• One-Year Outcomes of Patients With Established Coronary Artery Disease Presenting With Acute Coronary Syndromes.

  2019cites this paper
• Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention

  2019cites this paper
• Biodegradable-polymer versus polymer-free drug eluting stents for the treatment of coronary artery disease.

  2019cites this paper
• Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study

  2019cites this paper
• Wirelessly Heating Stents via Radiofrequency Resonance toward Enabling Endovascular Hyperthermia

  2019cites this paper
• Aspects of Heart Failure in Patients with Ischemic Heart Disease after Percutaneous Coronary Revascularization with Polymer-coated Drug-Eluting Stents versus Bare-Metal Stents

  2019cites this paper
• Incidence and risk factors for coronary Stent Thrombosis at AL Shifa Hospital-Gaza strip

  2019cites this paper
• SWEDEHEART-1-year data show no benefit of newer generation drug-eluting stents over bare-metal stents in patients with severe kidney dysfunction following percutaneous coronary intervention.

  2019cites this paper
• A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation

  2019cites this paper
• Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials

  2018cites this paper
• Procedural advantages of a novel coronary stent design with ultra-thin struts and bioabsorbable abluminal polymer coating in an all-comers registry

  2018cites this paper